行情

BSX

BSX

波士顿科学
NYSE

实时行情|Nasdaq Last Sale

41.81
-0.43
-1.02%
盘后: 41.90 +0.09 +0.22% 19:50 09/13 EDT
开盘
42.11
昨收
42.24
最高
42.45
最低
41.56
成交量
453.54万
成交额
--
52周最高
43.84
52周最低
31.56
市值
582.40亿
市盈率(TTM)
43.95
分时
5日
1月
3月
1年
5年

分析师评级

23位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

BSX 新闻

  • IoMT Becomes the Buzzword in New Age MedTech Investing
  • Zacks.1天前
  • BAX or BSX: Which Is the Better Value Stock Right Now?
  • Zacks.1天前
  • 心脉医疗、南微医学登陆科创板后,国产医疗器械迎来黄金时代?
  • 钛媒体.3天前
  • Morgan Stanley: Buy These 3 Stocks on Recent Weakness
  • TipRanks.4天前

更多

所属板块

先进医疗设备和技术
-0.04%
医疗设备和用品
-0.35%

热门股票

名称
价格
涨跌幅

BSX 简况

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.
展开

Webull提供Boston Scientific Corporation的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。